Physician profile
Matthew E Lovell
NPI 1427254515
$1,492.20
in general payments reported to CMS, 2019-2025
11 companies · $511 in 2025
The $511 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $184 · 2021: $177 · 2022: $29.53 · 2023: $332 · 2024: $158 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $450.01 | 2019-2025 | Blueprint Patient Specific Instrumentation, Asnis |
| Zimmer Biomet Holdings, INC. | $319.57 | 2019-2025 | Comprehensive Shoulder System, Rosa |
| Endo Pharmaceuticals INC. | $200.41 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $137.21 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $108.69 | 2020-2023 | Monovisc, Orthovisc |
| Mf Med | $103.51 | 2025 | |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Becton, Dickinson and Company | $41.87 | 2025 | Hemosphere |
| Djo, LLC | $28.70 | 2023-2024 | Cmf, Donjoy |
| Averitas Pharma INC. | $22.99 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lovell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.